CDS in pCMV-DsRed-Express (Takara) was fused with the nuclear localization signal taken from pRed H-Stinger (obtained from Bloomington DGRC). The resulting fragment was similarly linked to the attB1 site at the 5'-end and the attB2 site at the 3'-end by PCR, subcloned into pDONR221 with BP clonase, and then transferred into pMT-DEST48 with LR clonase. The expression vector pSvb:PA-GFP encoding a full-length Svb protein fused to photoactivatable GFP (S9) was obtained by inserting svb sequences in frame with PA-GFP ORF under the control of a constitutive actin5C promoter. To construct vectors expressing the full-length pri (pMT-pri), 1-4FS pri (pMT-1-4FS) and EGFP control (pMT-EGFP), each fragment in pDONR221 (S3) was transferred into pMT-DEST48 with LR clonase. To construct the luciferase reporter plasmids pGL4.11-Enh-m and pGL4.11-Enh-mKO, the wild-type and mutated enhancers fused with a minimal promoter fragment were subcloned into pGL4.11 (Promega) using the Xho I/Bgl II sites. The Renilla luciferase CDS was amplified by PCR from pGL4.74 (Promega) with the attB1 site at the 5'-end and attB2 at the 3'-end and cloned into pDONR221 with BP clonase, then transferred into pMT-DEST48 with LR clonase, giving rise to the pMT-Rluc vector, which was used to standardize transfection efficiency.
Antibody production. DNA fragments encoding the Svb-specific N-terminal extension (Svb1s, positions 1-136 aa) and a region common to all Ovo/Svb protein isoforms (Ovo, positions 982-1228) were subcloned into the pGEX (GE Healthcare) or pKLD116 (S10) vectors. GST or MBP fusion proteins were produced and purified according to the supplier's instructions and (S11), respectively. The purified proteins were used to immunize rabbits (Agrobio) and for subsequent purification of the immune sera by affinity chromatography.
Embryo staining and observation. Cuticle preparations were performed as previously described (S2, S3). Digoxigenin-labeled RNA antisense probes derived from cDNAs corresponding to miniature (CG9369), shavenoid (CG13209), CG16885, dusky-like (CG15013), forked (CG5424), trynity (CG17131), singed (CG32858), ovo/shavenbaby (CG6824) and polished rice (CR33327), were synthesized in vitro and processed for in situ hybridization following standard procedures, as described in (S2, S3). To identify mutant embryos, we used either a svb mutant chromosome carrying the btd 1 mutation (leading to head defects; a gift from E. Wieschaus), or embryos sorted using GFP-expressing derivatives of FM7c, TM3 or TM6B balancers (http://flystocks.bio.indiana.edu/).
Immunostaining was performed according to (S2), with anti-Miniature at 1/400 (S4),
anti-ß-galactosidase at 1/1000 (Cappel), Alexa Fluor 488-, 594-or 647-labeled secondary antibodies (Molecular Probes), and TO-PRO-3 (Molecular Probes) or DAPI for nuclear counterstaining (Sigma-Aldrich). We used affinity-purified anti-Svb1s (1/20) to detect the Svb-specific N-terminal region, and anti-GFP (Roche, 1/300) to detect its C-terminal region in pr-svb>>Svb:GFP embryos; the staining was revealed using a TSA amplification kit according to the manufacturer's specifications (Molecular Probes). Embryos were mounted in Vectashield (Vector Laboratories) and photographed with a Leica TSC SP2 confocal or Nikon Eclipse 90i microscope. Living embryos expressing GFP and DsRed were dechorionated using 50% bleach and mounted on glass slides with silicone oil (Shin-Etsu Silicones). The GFP and DsRed signals were detected by confocal microscopy (LSM5 Exciter, Carl Zeiss).
Luciferase assays and immunostaining in S2 cells. S2 cells were grown at 25 °C in Schneider's Drosophila medium (Invitrogen) containing 10% fetal calf serum, 100 units/ml penicillin and 100 μg/ml streptomycin. For luciferase assays, S2 cells (0.5x10 6 cells/500 μl)
were plated in 24-well plates. 24 hours after plating, the S2 cells were transfected with a mixture of 100 ng pMT-svb/ovo:Myc (or pMT-EGFP), 50 ng pMT-pri (or pMT-1-4FS), 50 ng pGL4.11-Emin400/400KO and 0.5 ng pMT-Rluc in 25 μl, with 1 μl of siLentFect Figure S6 . Analysis of the respective modifications of ovo/svb protein and mRNA products, following the expression of Pri peptides in S2 cells. The apparent size of ovo/svb mRNAs was not modified following expression of pri, or the 1-4FS construct used a negative control. The electrophoretic mobility of OvoA:Myc and OvoB:Myc proteins, were not either affected by the status of pri expression. In contrast, the mobility of the Svb:Myc protein became much faster upon pri expression, indicating a truncation of Svb. In some experiments, this truncated product appears more abundant than the full-length form, a feature possibly resulting from an increased stability of the protein and/or mRNA products. It is also possible that the repressor activity of full-length Svb affects cell viability or growth of transfected cells. Methylene blue staining of ribosomal RNA was used as a loading control. Figure S7 . (A) Western blots of protein extracts from S2 cells expressing OvoA:GFP, OvoB:GFP, Svb:GFP and Svb:GFP + Pri. Cell extracts were immunoprecipitated with an anti-GFP antibody, then separated by SDS-PAGE and analyzed by western blotting using an anti-GFP antibody. Detection of the truncated Svb isoform by anti-GFP showed that it contained an intact C-terminal region. (B) Ventral views of transgenic embryos that express Svb:GFP under control of the svb promoter, stained with anti-Svb1s (red) or anti-GFP (green). Svb:GFP was recognized by anti-GFP, but not by anti-Svb1s at stage 15, supporting that Svb:GFP was truncated at its N-terminus but retained an intact C-terminal region after onset of pri expression in embryos. Nuclei are in blue. Scale bar, 10 μm. On the other hand, the corresponding DNA sequence shows synonymous nucleotide substitutions among insect species, supporting that the selective pressure has applied to the protein rather than on the RNA sequence. Although CUG, GUG or ACG have been documented as alternative initiation codons (S12), there is no reported evidence of the use of GGC, the codon for this N-terminal Alanine (and also that of the immediately upstream residue). These results strongly suggest that Svb truncation does not result from alternative translation, but rather on a proteolytic maturation. Figure S9 . svb is not required for tracheal taenidium formation. Differential interference contrast microscopy of the tracheal taenidiae in wild-type embryos showed the characteristic pattern of folds perpendicular to the longitudinal axis of the tracheal dorsal trunk (top). These regular taenidiae were absent in embryos lacking pri (pri 2 /pri 3 , middle panel), but were not affected in svb mutant embryos (svb R9 /Y; bottom). Scale bar, 10 μm.
